NCT00144560已完成不适用
An Open-Label, Clinical Pharmacology Study to Investigate Drug-Drug Interaction in Patients With RA
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 31
- 主要终点
- 20% improvement based on the ACR criteria compared with the baseline value.
研究概览
简要总结
This is an open-label, clinical pharmacology study to investigate drug-drug interaction in patients with RA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
20% improvement based on the ACR criteria compared with the baseline value.
时间窗: throughout study
次要结局
- Time courses taken from baseline values for DAS28, for ACR20%, 50%, and 70% improvement, and for each ACR core set variable.(Week 0,Week 1, Week 2)
研究者
相似试验
已完成
1 期
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult MenHealthy VolunteersNCT01588782Janssen Research & Development, LLC20
已完成
1 期
Lesinurad Interaction Study With RanitidineHealthyNCT01908257Ardea Biosciences, Inc.16
已完成
1 期
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male SubjectsBenign Prostate HyperplasiaNCT02839122Yuyu Pharma, Inc.28
已完成
1 期
Evaluation of the Pharmacokinetic Drug-drug Interactions Between VX-993 and Metformin in Healthy AdultsPainNCT06523595Vertex Pharmaceuticals Incorporated31
已完成
1 期
Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy ParticipantsHealthy VolunteersNCT05665647Jiangsu Simcere Pharmaceutical Co., Ltd.36